Drugs

Centre proposes easing shelf-life, licensing norms for imported drugs

Draft amendments propose a 12-month minimum residual shelf life for imported drugs and an acknowledgement-based mechanism for importing medicines for research

Alembic Pharma gets USFDA nod for drug to treat influenza A and B in babies

The drug that has received the final approval from the US regulatory body is Oseltamivir Phosphate for Oral Suspension, 6 mg/mL

Centre brings vaccines, anti-cancer drugs under QR code tracking regime

The Health Ministry will expand mandatory QR code-based traceability to vaccines, antimicrobials, anti-cancer, narcotic and psychotropic drugs in a phased rollout

No sale of syrups without doctor's prescription; here's what govt did

The Centre has amended the Drugs Rules, 1945 and removed 'syrups' from a category under Schedule K, amid tighter oversight of cough syrups and drug safety

'US strike on Tren de Aragua leader shows Trump's approach to war on drugs'

The US military attack in Venezuela Friday that killed the leader of the Tren de Aragua gang reflects a strategic shift by US President Donald Trump toward direct US involvement in the war on drugs that began earlier this year, with a special focus this time on gaining access to Venezuela's lucrative mining sector, analysts told The Associated Press. Trump announced Friday the death of gang leader Hector Rusthenford Guerrero in an airstrike on his compound in rural Venezuela. He has long accused Guerrero's organisation, also known as TDA, of terrorising communities across the United States, where it has been linked to extortion rackets, drug trafficking and illegal immigration. The group was listed as a foreign terrorist organization by the State Department last year, with federal prosecutors accusing Guerrero of shipping drugs to the U.S. and organizing acts of terror across borders, including the murder of a Venezuelan dissident in Chile. Venezuela's government said in a statement

Scheme to build bulk drugs' R&D, capacity in works, says Pharma secy

India plans a new support scheme for bulk drugs focused on R&D and capacity creation, while ruling out a broad medicine price hike despite rising input costs

Eli Lilly and Novo Nordisk looking beyond US for obesity drug growth

Novo Nordisk and Eli Lilly are expanding obesity drug access globally as demand grows beyond the US and cheaper semaglutide generics enter new markets

Beyond GLP-1, Novo eyes next-gen obesity drugs: Vikrant Shrotriya

Novo Nordisk plans to defend its obesity drug leadership in India as semaglutide patent expiry fuels competition from nearly 50 new market entrants

NPPA fixes prices of 30 drugs including Vitamin D3, calcium supplements

According to the order, the fixed retail prices are exclusive of Goods and Services Tax (GST), which may be added only if it has actually been paid or is payable to the government.

France becomes first EU country to reimburse anti-obesity drugs: Minister

Patients in France are currently paying around €300 ​per month on average for the drugs, she said, without indicating how many people currently follow such treatments

Govt to amend anti-doping law, proposes five-year jail for suppliers

Sports Minister Mansukh Mandaviya on Thursday said the National Anti Doping Act will be amended to criminalise trafficking and distribution of prohibited substances with a jail term of upto five years. The amendments have been uploaded on the sports ministry's website for requisite feedback from the public. "Whoever administers or applies to an athlete, for the purpose of or in connection with doping in sport...shall be punishable with imprisonment for a term which may extend to (five) years, or with fine which may extend up to (two lakh) rupees, or both," the amendment states. Mandaviya said the amended bill will be tabled in the next session of Parliament. "Doping is no longer just a sporting violation; it has evolved into an organised ecosystem exploiting athletes," Mandaviya said in an interaction with the media here. "We only punish those who are consuming but suppliers need to be targetted as well," he added.

AIOCD to go ahead with May 20 strike despite states opting out of protest

AIOCD will continue with its proposed nationwide strike against online pharmacies despite several state retail pharmacy associations opting out of the protest

India joins weight-loss drug race, but affordability remains a concern

India is in the race for a new class of weight-loss drugs, but the question is: Will they be affordable?

CDSCO asks firms to file safety reports from launch date of new drugs

India's drug regulator has directed manufacturers and importers to submit Periodic Safety Update Reports (PSURs) for new drugs from the date of actual marketing of the product rather than from the date of regulatory approval, in a move aimed at strengthening post-marketing safety surveillance. In an advisory issued by the Central Drugs Standard Control Organisation (CDSCO) on April 21, the regulator said it has observed instances where companies obtained approval for a new drug but launched the product in the market much later while submitting PSUR data from the approval date instead of the launch date. The CDSCO said such a practice results in the loss of "valuable safety insights" that are critical for monitoring adverse effects and ensuring patient safety after commercial roll out of medicines. Under the Fifth Schedule of the New Drugs and Clinical Trials Rules, 2019, manufacturers and importers are required to submit PSURs as part of post-marketing drug safety monitoring. "In v

Respiratory drug sales rise 17.7% in April on seasonal flu, asthma rise

Respiratory drug sales outpaced overall pharmaceutical market growth in April, driven by seasonal flu, pollution, and rising asthma and COPD cases

Generic GLP-1 sales increase, but innovators retain market share

Over 25 versions of weight-loss drugs currently available in the market

NCB busts narcotics ring, cocaine worth ₹1,745 cr seized in Mumbai: Shah

Union Home Minister Amit Shah on Friday said the Narcotics Control Bureau has busted a major international narcotics ring, seizing 349 kilograms of high-grade cocaine worth Rs 1,745 crore in Mumbai. Announcing the seizure on microblogging platform X, Shah said, "We are resolved to ruthlessly crush the narcotics cartel." "The @narcoticsbureau has cracked down on a major international narcotics ring, seizing 349 kg of high-grade cocaine worth Rs 1,745 crore in Mumbai. This is a trailblazing example of a bottom-to-top approach where the agency traced back a smaller consignment to net a massive network. Congratulations to Team NCB for this monumental success," he said. The seizure comes days after Salim Dola, a drug trafficker and aide of international terrorist Dawood Ibrahim, was brought to India from Turkiye.

Centre revises DCGI recruitment rules, raises age limit to widen pool

The Centre has raised the age limit and broadened eligibility norms for appointing the Drug Controller General of India to address a shortage of qualified candidates

Fake Mounjaro injection manufacturing racket busted in Gurugram; 2 arrested

Authorities have unearthed a racket involving the manufacturing and sale of "fake" Mounjaro (tirzepatide) injections and arrested two persons here in this connection, an official said on Monday. A nationwide alert has been issued to detect the counterfeit injections and an investigation is underway to unravel the entire network, including all those involved in this racket, Drug Control Officer Amandeep Chauhan said. He said a Health Department team raided a residential society in Sector 62 on Monday and arrested two people, including the key accused. The accused were importing raw drugs from China and manufacturing counterfeit injections of Mounjaro. The entire racket was being run from a flat in the society. The accused supplied these illegal injections through the B2B portal Indiamart, the officer alleged. Mounjarois a weekly injectable medication for type 2 diabetesthat significantly improves blood sugar control and aids weight loss. "We received information about a fake inject

Lilly backs regulatory action after fake Mounjaro seizure in Gurugram

Drugmaker highlights patient safety risks and pledges cooperation with authorities after seizure of suspected counterfeit Mounjaro products in Gurugram